Radioimmunotherapy as a Therapeutic Option for Non-Hodgkin’s Lymphoma
- 31 July 2007
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 17 (3), 176-183
- https://doi.org/10.1016/j.semradonc.2007.02.003
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Review of clinical radioimmunotherapyExpert Review of Anticancer Therapy, 2006
- Rituximab Therapy for Patients With Newly Diagnosed, Advanced-Stage, Follicular Grade I Non-Hodgkin's Lymphoma: A Phase II Trial in the North Central Cancer Treatment GroupJournal of Clinical Oncology, 2005
- Radiobiology of radioimmunotherapy: Targeting CD20 B-cell antigen in non-Hodgkin's lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2004
- Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2002
- Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+B-Cell Non-Hodgkin's LymphomaJournal of Clinical Oncology, 1999
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Radithor and the Era of Mild Radium TherapyJAMA, 1990
- Dosimetry and treatment planning for 90Y-labelled antiferritin in hepatomaInternational Journal of Radiation Oncology*Biology*Physics, 1988